Therefore, these data suggest that the inhibition of angiogenesis in vitro by PL is mediated, to some extent, through the suppression of AKT activity, which results in the suppression of secretion of VEGF from breast cancer cells. The gene discussed is VEGFA; the disease is breast cancer.